Zhitong Finance App learned that on December 26, the China Securities Regulatory Commission announced the “Requirements for Supplementary Materials for Overseas Issuance and Listing Filing (December 22, 2025 to December 26, 2025)”. The International Department of the China Securities Regulatory Commission announced supplementary material requirements for 19 companies. Among them, Haina Pharmaceuticals was requested to provide additional information on matters such as the specific use of funds raised and the share of domestic and foreign use. According to reports, Haina Pharmaceuticals submitted a statement to the Hong Kong Stock Exchange on November 7, 2025, with CICC as the sole sponsor.

Zhitong Finance App learned that on December 26, the China Securities Regulatory Commission announced the “Requirements for Supplementary Materials for Overseas Issuance and Listing Filing (December 22, 2025 to December 26, 2025)”. The International Department of the China Securities Regulatory Commission announced supplementary material requirements for 19 companies. Among them, Haina Pharmaceuticals was requested to provide additional information on matters such as the specific use of funds raised and the share of domestic and foreign use. According to reports, Haina Pharmaceuticals submitted a statement to the Hong Kong Stock Exchange on November 7, 2025, with CICC as the sole sponsor.